Supriya Life Sciences Q3 Results 2025:Supriya Life Sciences declared their Q3 results on 24 Jan, 2025, revealing impressive financial performance for the quarter. The company reported a topline increase of 32.54% year-on-year, with profits soaring by 57.03%. The profit for the quarter stood at ₹46.78 crore, while revenue reached ₹185.65 crore.
Despite the strong year-on-year growth, the company faced challenges compared to the previous quarter, where revenue and profit saw declines of 43.18% and 48.47%, respectively. Notably, Selling, General & Administrative expenses decreased by 50.29% quarter-over-quarter but increased by 12.59% year-on-year.
The operating income also experienced a downturn, decreasing by 48.25% quarter-over-quarter but showing an increase of 62.51% year-over-year. The Earnings Per Share (EPS) for Q3 was reported at ₹5.82, marking a 57.3% increase compared to the same quarter last year.
Supriya Life Sciences has delivered a 9.47% return over the last week and an impressive 90.62% return over the past six months, although it reported a slight decline of -1.28% Year-to-Date.
As of 25 Jan, 2025, Supriya Life Sciences boasts a market capitalization of ₹5,878.06 crore, with a 52-week high of ₹835.2 and a low of ₹288.9. Analysts remain optimistic, with 1 out of 1 covering analysts giving the stock a ‘Strong Buy’ rating.
The consensus recommendation as of 25 Jan, 2025, is to Strong Buy, indicating confidence in the company’s future performance and growth potential.
Supriya Life Sciences Financials
| Period | Q3 (FY25) | Q2 (FY25) | Q-o-Q Growth | Q3 (FY24) | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 185.65 | 326.73 | -43.18% | 140.07 | +32.54% |
| Selling/ General/ Admin Expenses Total | 19.77 | 39.77 | -50.29% | 17.56 | +12.59% |
| Depreciation/ Amortization | 4.96 | 9.4 | -47.23% | 3.96 | +25.25% |
| Total Operating Expense | 124.66 | 208.87 | -40.32% | 102.55 | +21.56% |
| Operating Income | 60.99 | 117.86 | -48.25% | 37.53 | +62.51% |
| Net Income Before Taxes | 62.58 | 121.84 | -48.64% | 40.1 | +56.06% |
| Net Income | 46.78 | 90.79 | -48.47% | 29.79 | +57.03% |
| Diluted Normalized EPS | 5.82 | 11.28 | -48.4% | 3.7 | +57.3% |
Disclaimer: This is an AI-generated live blog and has not been edited by LiveMint staff.